Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma.

Enrico DerenziniValentina TabanelliSimona SammassimoSaveria MazzaraGiovanna MottaFederica MelleAnna VanazziAngelica CalleriStefano FioriMaria Chiara FinazziMaria Chiara BarbantiSafaa RamadanSara GandiniRocco PastanoAlessandro RambaldiStefano PileriCorrado Tarella

Published in: Bone marrow transplantation (2021)

Keyphrases

stem cell transplantation
high dose
diffuse large b cell lymphoma
free survival
low dose
bone marrow